VarmX and Rentschler Biopharma expand collaboration from early development to late ‑ stage and commercial manufacturing of VMX-C001 VMX ‑ C001 ...

LONDON — There appears to be no advantage for continuing anticoagulation treatment after primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI), according to ...

Please provide your email address to receive an email when new articles are posted on . Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents ...

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...

New observational data showed no significant difference in subsequent ischemic stroke with anticoagulation compared with antiplatelet therapy, although there was a nonsignificant trend toward a lower ...

PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...

A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was diagnosed, it was more likely ...

PONTE VEDRA, FL / / December 29, 2025 / Every industry has its forgotten corners. In anticoagulation, those corners turned ...

If you are diagnosed with a deep vein thrombosis (DVT), a blood clot in one of your deep veins, you may assume that you need to be treated in the hospital. But that’s not always the case. In fact, ...